The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response rates, toxicity, and quality of life for locally regionally advanced head and neck squamous cell carcinoma after induction chemotherapy with weekly nab-paclitaxel, carboplatin, and cetuximab.
 
Jared Weiss
Stock and Other Ownership Interests - Pharmacyclics
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology
Research Funding - Acceleron Pharma; Astellas Pharma; Celgene; GlaxoSmithKline; MedImmune; Pfizer
 
Jill Gilbert
No Relationships to Disclose
 
Juneko E. Grilley-Olson
Consulting or Advisory Role - Sanofi
Research Funding - Bayer; GlaxoSmithKline; Kyowa Hakko Kirin; Morphotek; NanoCarrier; Novartis; Peregrine Pharmaceuticals; ZIOPHARM Oncology
 
Allison Mary Deal
No Relationships to Disclose
 
Bhishamjit S. Chera
Employment - Tomotherapy
 
Jay Justin Liao
No Relationships to Disclose
 
Barbara A. Murphy
Honoraria - Bristol-Myers Squibb; Eisai; Teva
Speakers' Bureau - Teva
Research Funding - BioAlliance Pharma
 
Mark C Weissler
Stock and Other Ownership Interests - Allergan; Baxter; cardinal health; carefusion; Express Scripts; Johnson & Johnson; Medtronic; Merck; Novartis; Pfizer; Stryker; Zimmer
 
David N. Hayes
No Relationships to Disclose